Navidea Biopharmaceuticals, Inc. Email Format

BiotechnologyUnited States11-50 Employees

Navidea Biopharmaceuticals, Inc. is a United States-based biotechnology company focused on immuno-targeting through its Manocept platform, with the aim of identifying disease sites and pathways to improve diagnostic accuracy, clinical decision-making, and targeted treatment. The company’s lead product, Lymphoseek, was approved by the FDA in 2013 and by European regulators in 2014, reflecting its approach to directing immune cell–targeted diagnostics to cancer, autoimmune, and inflammatory conditions. Navidea serves the medical community seeking precision immunodiagnostics and immunotherapies, aiming to support better patient care by enabling more informed clinical decisions and targeted interventions. Based in the United States, the company has pursued global partnering and commercialization as part of its strategy to advance its pipeline and product portfolio within the biotechnology research industry.

Sign up for free to view info

Company overview Employee directory